Clinical trial

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

NCT00659373

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-12-01

PhasePHASE3

Study timeline

Study start (unknown)2007-12-01Date precision: month

Registry last updated2016-07-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Fatigueunresolved

Sleep Disordersunresolved

Interventions

TamoxifenDRUG · verified · RxNorm: tamoxifen

triptorelinDRUG · verified · RxNorm: triptorelin

ExemestaneDRUG · verified · RxNorm: exemestane

Sponsors & collaborators

ETOP IBCSG Partners Foundationlead sponsor

National Cancer Institute (NCI)collaborator

Breast Cancer Trials, Australia and New Zealandcollaborator

Cancer and Leukemia Group Bcollaborator

Mapped research locations

AtlantaGeorgia, United States4 PhiladelphiaPennsylvania, United States1 SacramentoCalifornia, United States1 OttawaOntario, Canada1 AshevilleNorth Carolina, United States1 South BendIndiana, United States1 Fort CollinsColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00659373 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.